These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28931820)

  • 1. The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma.
    Mroczek S; Chlebowska J; Kuliński TM; Gewartowska O; Gruchota J; Cysewski D; Liudkovska V; Borsuk E; Nowis D; Dziembowski A
    Nat Commun; 2017 Sep; 8(1):619. PubMed ID: 28931820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAM46C controls antibody production by the polyadenylation of immunoglobulin mRNAs and inhibits cell migration in multiple myeloma.
    Herrero AB; Quwaider D; Corchete LA; Mateos MV; García-Sanz R; Gutiérrez NC
    J Cell Mol Med; 2020 Apr; 24(7):4171-4182. PubMed ID: 32141701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of
    Zhu YX; Shi CX; Bruins LA; Jedlowski P; Wang X; Kortüm KM; Luo M; Ahmann JM; Braggio E; Stewart AK
    Cancer Res; 2017 Aug; 77(16):4317-4327. PubMed ID: 28619709
    [No Abstract]   [Full Text] [Related]  

  • 4. The Interaction of the Tumor Suppressor FAM46C with p62 and FNDC3 Proteins Integrates Protein and Secretory Homeostasis.
    Fucci C; Resnati M; Riva E; Perini T; Ruggieri E; Orfanelli U; Paradiso F; Cremasco F; Raimondi A; Pasqualetto E; Nuvolone M; Rampoldi L; Cenci S; Milan E
    Cell Rep; 2020 Sep; 32(12):108162. PubMed ID: 32966780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional characterization of multiple myeloma associated cytoplasmic poly(A) polymerase FAM46C.
    Zhang H; Zhang SH; Hu JL; Wu YT; Ma XY; Chen Y; Yu B; Liao S; Huang H; Gao S
    Cancer Commun (Lond); 2021 Jul; 41(7):615-630. PubMed ID: 34048638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-canonical RNA polyadenylation polymerase FAM46C is essential for fastening sperm head and flagellum in mice†.
    Zheng C; Ouyang YC; Jiang B; Lin X; Chen J; Dong MZ; Zhuang X; Yuan S; Sun QY; Han C
    Biol Reprod; 2019 Jun; 100(6):1673-1685. PubMed ID: 31087039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and Autophagy.
    Manfrini N; Mancino M; Miluzio A; Oliveto S; Balestra M; Calamita P; Alfieri R; Rossi RL; Sassoè-Pognetto M; Salio C; Cuomo A; Bonaldi T; Manfredi M; Marengo E; Ranzato E; Martinotti S; Cittaro D; Tonon G; Biffo S
    Cancer Res; 2020 Nov; 80(21):4693-4706. PubMed ID: 32963011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biallelic loss of FAM46C triggers tumor growth with concomitant activation of Akt signaling in multiple myeloma cells.
    Kanasugi J; Hanamura I; Ota A; Karnan S; Lam VQ; Mizuno S; Wahiduzzaman M; Rahman ML; Hyodo T; Konishi H; Tsuzuki S; Hosokawa Y; Takami A
    Cancer Sci; 2020 May; 111(5):1663-1675. PubMed ID: 32176823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The non-canonical poly(A) polymerase FAM46C promotes erythropoiesis.
    Yang K; Zhu T; Yin J; Zhang Q; Li J; Fan H; Han G; Xu W; Liu N; Lv X
    J Genet Genomics; 2024 Jun; 51(6):594-607. PubMed ID: 38403115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells.
    Zhang QY; Yue XQ; Jiang YP; Han T; Xin HL
    Sci Rep; 2017 Mar; 7(1):396. PubMed ID: 28341836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and Functional Analyses of the FAM46C/Plk4 Complex.
    Chen H; Lu D; Shang G; Gao G; Zhang X
    Structure; 2020 Aug; 28(8):910-921.e4. PubMed ID: 32433990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAM46C inhibits lipopolysaccharides-induced myocardial dysfunction via downregulating cellular adhesion molecules and inhibiting apoptosis.
    Tan J; Sun T; Shen J; Zhu H; Gong Y; Zhu H; Wu G
    Life Sci; 2019 Jul; 229():1-12. PubMed ID: 30910647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immunity-malignancy equilibrium in multiple myeloma: lessons from oncogenic events in plasma cells.
    Perini T; Materozzi M; Milan E
    FEBS J; 2022 Aug; 289(15):4383-4397. PubMed ID: 34117720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma.
    Zhang W; Wu C; Geng S; Wang J; Yan C; Zhang X; Zhang JJ; Wu F; Pang Y; Zhong Y; Wang J; Fu W; Huang X; Wang W; Lyu X; Huang Y; Jing H
    Aging (Albany NY); 2023 May; 15(9):3644-3677. PubMed ID: 37155154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compendium of FAM46C gene mutations in plasma cell dyscrasias.
    Barbieri M; Manzoni M; Fabris S; Ciceri G; Todoerti K; Simeon V; Musto P; Cortelezzi A; Baldini L; Neri A; Lionetti M
    Br J Haematol; 2016 Aug; 174(4):642-5. PubMed ID: 26456599
    [No Abstract]   [Full Text] [Related]  

  • 16. RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma.
    Lee HC; Wang H; Baladandayuthapani V; Lin H; He J; Jones RJ; Kuiatse I; Gu D; Wang Z; Ma W; Lim J; O'Brien S; Keats J; Yang J; Davis RE; Orlowski RZ
    Br J Haematol; 2017 Apr; 177(1):80-94. PubMed ID: 28369725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAM46 proteins are novel eukaryotic non-canonical poly(A) polymerases.
    Kuchta K; Muszewska A; Knizewski L; Steczkiewicz K; Wyrwicz LS; Pawlowski K; Rychlewski L; Ginalski K
    Nucleic Acids Res; 2016 May; 44(8):3534-48. PubMed ID: 27060136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Execution of BMP-4-induced apoptosis by p53-dependent ER dysfunction in myeloma and B-cell hybridoma cells.
    Fukuda N; Saitoh M; Kobayashi N; Miyazono K
    Oncogene; 2006 Jun; 25(25):3509-17. PubMed ID: 16449972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TENT5-mediated polyadenylation of mRNAs encoding secreted proteins is essential for gametogenesis in mice.
    Brouze M; Czarnocka-Cieciura A; Gewartowska O; Kusio-Kobiałka M; Jachacy K; Szpila M; Tarkowski B; Gruchota J; Krawczyk P; Mroczek S; Borsuk E; Dziembowski A
    Nat Commun; 2024 Jun; 15(1):5331. PubMed ID: 38909026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the Puzzling Roles of FAM46C: A Multifaceted Pan-Cancer Tumour Suppressor with Increasing Clinical Relevance.
    Lai G; De Grossi F; Catusi I; Pesce E; Manfrini N
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.